Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209821
Company: EDENBRIDGE PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
MIGLUSTAT MIGLUSTAT 100MG CAPSULE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
08/06/2020 ORIG-1 Approval STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/10/2021 SUPPL-1 Labeling-Proprietary Name Change

Label is not available on this site.

MIGLUSTAT

CAPSULE;ORAL; 100MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
MIGLUSTAT MIGLUSTAT 100MG CAPSULE;ORAL Prescription No AB 208342 ANI PHARMS
MIGLUSTAT MIGLUSTAT 100MG CAPSULE;ORAL Prescription No AB 209821 EDENBRIDGE PHARMS
ZAVESCA MIGLUSTAT 100MG CAPSULE;ORAL Prescription Yes AB 021348 ACTELION

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English